Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans |
| |
Authors: | Etchart Nathalie Hennino Ana Friede Martin Dahel Karima Dupouy Monique Goujon-Henry Catherine Nicolas Jean-François Kaiserlian Dominique |
| |
Affiliation: | INSERM U404, Lyon F-69007, France; Université Lyon 1, Lyon F-69003, France; IFR128, Lyon F-69007, France. |
| |
Abstract: | Transcutaneous immunisation (TCI) using a skin patch is a non-invasive vaccination route relevant to mass vaccination against infectious diseases. This phase I/II clinical study, documents that TCI of human adult volunteers with the live-attenuated measles vaccine ROUVAX((R)) is safe and poorly reactogenic. It promotes induction of measles-specific salivary IgA and a tendency to increased frequency of MV-specific IFNgamma-producing T cells. However, in contrast to the subcutaneous route, TCI failed to evoke neutralising MV-specific serum antibodies. Thus, alternative delivery methods and/or devices providing optimal uptake by skin DC should be considered for live-attenuated virus vaccines, such as the measles vaccine. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|